Measured Wealth Private Client Group, LLC Novartis Ag Transaction History

Measured Wealth Private Client Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$78.07 - $94.43 $216,878 - $262,326	-2,778 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$82.14 - $91.0 $228,184 - $252,798	2,778 New	2,778 $242,000
Q1 2020 Apr 22, 2020	SELL	$70.67 - $99.01 $186,427 - $261,188	-2,638 Closed	0 $0
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $64,105 - $72,481	-760 Reduced 22.37%	2,638 $250,000
Q3 2019 Oct 11, 2019	SELL	$85.54 - $94.26 $260,041 - $286,550	-3,040 Reduced 47.22%	3,398 $295,000
Q2 2019 Jul 26, 2019	SELL	$75.4 - $92.8 $52,026 - $64,032	-690 Reduced 9.68%	6,438 $588,000
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $117,348 - $134,221	1,558 Added 27.97%	7,128 $685,000
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $4,051 - $4,511	-55 Reduced 0.98%	5,570 $478,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $6,359 - $7,355	95 Added 1.72%	5,625 $485,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $358,952 - $405,680	5,530 New	5,530 $417,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.